A Gene Panel Associated With Abemaciclib Utility in <i>ESR1</i>-Mutated Breast Cancer After Prior Cyclin-Dependent Kinase 4/6-Inhibitor ProgressionJamie O. Brett, Seth A. Wander, Taronish D. Dubash et al.|JCO Precision Oncology|2023Cited by 16
Solid tumour-induced systemic immunosuppression involves dichotomous myeloid–B cell interactionsXiaoxin Hao, Xiang H.-F. Zhang, Liqun Yu et al.|Nature Cell Biology|2024Cited by 16
Abstract PD2-03: Association between co-existing genomic alterations and abemaciclib benefit in patients with metastatic hormone receptor-positive breast cancer with ESR1 mutations following disease progression on prior endocrine therapy plus palbociclib or ribociclibJamie O. Brett, Seth A. Wander, Taronish D. Dubash et al.|Cancer Research|2022Cited by 1